Pain Medicine, Interventional Pain Medicine · Houma, LA
NPI
1932379872
Since 2008
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1022 Belanger St
Houma, LA, 70360
Phone (985) 223-3132
Groups this clinician bills Medicare through
Medicare paid, 2024
$165K
2,508 services
Medicare patients, 2024
207
Average age 71
Drug cost, 2024
$477K
7,730 prescriptions
Company payments, 2025
$854
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Keith P Duplantis was code 99214 (office e&m - established), 974 times for 190 patients. In total Keith P Duplantis billed 2,508 services in 43 codes, and Medicare paid $165K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 974 | 190 | $89.43 | $87K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 310 | 26 | $0.09 | $27.68 |
| 99152 Anesthesia | Facility | 259 | 117 | $8.75 | $2,266 |
| 0627T Musculoskeletal | Facility | 107 | 56 | $69.34 | $7,420 |
| 99204 Office E&M - New | Office | 76 | 76 | $107.14 | $8,142 |
| 64493 Nerve Block Injection - Back | Facility | 60 | 32 | $84.73 | $5,084 |
| 64494 Nerve Block Injection - Back | Facility | 59 | 32 | $48.35 | $2,853 |
| 80307 Drug Tests | Office | 55 | 52 | $60.16 | $3,309 |
| 64490 Nerve Block Injection - Back | Facility | 55 | 33 | $97.91 | $5,385 |
| 64491 Nerve Block Injection - Back | Facility | 54 | 33 | $55.33 | $2,988 |
| 27096 Joint Injection | Facility | 50 | 41 | $64.98 | $3,249 |
| 99213 Office E&M - Established | Office | 43 | 23 | $51.98 | $2,235 |
| 20610 Joint Injection | Office | 41 | 24 | $52.47 | $2,151 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 40 | 38 | $192.85 | $7,714 |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 40 | 38 | $59.06 | $2,363 |
By year: 2022 $169K for 2,149 services; 2023 $132K for 1,668 services; 2024 $165K for 2,508 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 55 | 52 | $60.16 | $3,309 |
Medicare prescription drug claims, 2024
In 2024, the drug Keith P Duplantis prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,313 prescriptions and refills. In total Keith P Duplantis wrote 7,730 Medicare prescriptions that cost $477K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,313 | 1,313 | 277 | $31K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,232 | 1,233 | 179 | $31K |
| Meloxicam Generic | 714 | 1,010 | 198 | $1,863 |
| Amitriptyline Hcl Generic | 699 | 1,068 | 183 | $9,353 |
| Chlorzoxazone Generic | 491 | 611 | 141 | $31K |
| Pregabalin Generic | 482 | 648 | 121 | $7,851 |
| Gabapentin Generic | 385 | 669 | 96 | $8,309 |
| Tizanidine Hcl Generic | 259 | 510 | 57 | $5,338 |
| Tramadol Hcl Generic | 216 | 216 | 64 | $1,417 |
| Celecoxib Generic | 194 | 255 | 51 | $3,963 |
| Cyclobenzaprine Hcl Generic | 143 | 182 | 41 | $2,665 |
| Trazodone Hcl Generic | 139 | 245 | 32 | $906 |
| Baclofen Generic | 132 | 196 | 44 | $2,140 |
| Morphine Sulfate Generic | 107 | 107 | 17 | $1,956 |
| Morphine Sulfate Er Morphine Sulfate | 100 | 100 | 17 | $2,689 |
Brand drugs: 446 claims; generic drugs: 7,284 claims; opioid claims: 3,244.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Keith P Duplantis $854 ($854 in general payments such as food, travel and fees) from 10 companies. The largest payer was BIOTRONIK NRO, Inc. with $255.
| Company | Payments | Amount |
|---|---|---|
| BIOTRONIK NRO, Inc. | 6 | $255 |
| Abbvie Inc. ABBV | 16 | $181 |
| Collegium Pharmaceutical, Inc. COLL | 5 | $104 |
| Pfizer Inc. PFE | 5 | $95.42 |
| Boston Scientific Corporation BSX | 3 | $77.55 |
| Fidia Pharma USA Inc. | 3 | $66.86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $30.75 |
| Azurity Pharmaceuticals, Inc. | 1 | $15.11 |
| Axsome Therapeutics, Inc. AXSM | 1 | $14.68 |
| HydroCision, Inc. | 1 | $13.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.